Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00841529 · ClinicalTrials.gov registry record · Phase 2
Evaluation of the Cardioblate Closure Device in Facilitating Occlusion of the Left Atrial Appendage
A Phase 2 study, sponsored by Medtronic Cardiovascular.
- Terminated
- Registry status
- Phase 2
- Development phase
- 40
- Enrollment target
NCT00841529 is a Phase 2 study that was terminated before completion, run by Medtronic Cardiovascular. The registered enrollment target is 40 participants.
The verdict
NCT00841529, a Phase 2 study, was terminated before completion, sponsored by Medtronic Cardiovascular.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 40 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the performance of the Cardioblate Closure Device to occlude the LAA
Interventions
- DEVICE Medtronic LAA Occlusion Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2009-03 |
| Est. Completion | 2010-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00841529
The ClinicalTrials.gov registry entry for NCT00841529 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiovascular, which has 44 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Medtronic LAA Occlusion Device is the first listed.
NCT00841529 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00841529 about?
NCT00841529 is a clinical study titled "Evaluation of the Cardioblate Closure Device in Facilitating Occlusion of the Left Atrial Appendage". The purpose of this study is to evaluate the performance of the Cardioblate Closure Device to occlude the LAA
What is the current status of trial NCT00841529?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 40 participants. The study started on 2009-03. Estimated completion is 2010-06.
What interventions are being tested in trial NCT00841529?
The interventions under investigation include: Medtronic LAA Occlusion Device (DEVICE).
Who is sponsoring clinical trial NCT00841529?
This trial is sponsored by Medtronic Cardiovascular, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.